• about
    • consulting
    • quality audit
    • training
  • training
  • news
  • contact
Menu

ComplianceLogix

  • about
  • services
    • consulting
    • quality audit
    • training
  • training
  • news
  • contact
×

compliance news

Remote_Audits.jpg

Best Practices for Remote Audits

Brett Vengroff May 12, 2020

The coronavirus (COVID-19) pandemic has forced biotechnology, pharmaceutical, and medical device companies to suspend normal operations and transition to new and innovative ways of doing business. With current restrictions on international and domestic travel, traditional on-site audits are not possible, exposing organizations to increased compliance risk. In some cases, remote audits may provide a viable alternative to ensure continued compliance and oversight. This article will summarize best practices for selecting and conducting remote internal and external audits.

Read More
In GCP, GLP, GMP, remote audit, audit Tags remote, audit, remote audit, audits, GCP audit, GMP audit

Subscribe

Sign up with your email address to receive news and updates.

We respect your privacy.

Thank you!

Search Posts

Featured Posts

Featured
Oct 25, 2023
FDA Issues Draft Guidance for Remote Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities
Oct 25, 2023
Oct 25, 2023
Sep 16, 2022
Draft FDA Guidance for Computer Software Assurance for Production and Quality System Software
Sep 16, 2022
Sep 16, 2022
Aug 22, 2022
FDA Responses to Good Clinical Practice Inquiries
Aug 22, 2022
Aug 22, 2022
Apr 8, 2022
ICH E8(R1) General Considerations for Clinical Studies
Apr 8, 2022
Apr 8, 2022
Aug 31, 2021
Conduct of Clinical Trials During the COVID-19 Public Health Emergency
Aug 31, 2021
Aug 31, 2021

© 2024 ComplianceLogix, LLC    Terms of Use